11/29
12:31 am
indp
Indaptus Therapeutics (NASDAQ:INDP) was upgraded by analysts at
Wall Str
High
Report
Indaptus Therapeutics (NASDAQ:INDP) was upgraded by analysts at
Wall Str
11/17
08:00 am
indp
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
Medium
Report
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
11/12
10:31 am
indp
Indaptus Therapeutics GAAP EPS of -$2.98 [Seeking Alpha]
Low
Report
Indaptus Therapeutics GAAP EPS of -$2.98 [Seeking Alpha]
11/12
08:30 am
indp
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update